Explore

Trendline Trendline
Newron Pharmaceuticals to Engage Investors at June 2026 Conferences in New York and Virtually

Newron Pharmaceuticals to Engage Investors at June 2026 Conferences in New York and Virtually

Newron Pharmaceuticals to Engage Investors at June 2026 Conferences in New York and Virtually
Trendline Trendline
Vyome Holdings Reports Q1 2026 Financial Results and Strategic Developments

Vyome Holdings Reports Q1 2026 Financial Results and Strategic Developments

Vyome Holdings Reports Q1 2026 Financial Results and Strategic Developments
Trendline Trendline
Pfizer and Innovent Biologics Forge $10.5 Billion Oncology Partnership, Boosting Innovent Shares

Pfizer and Innovent Biologics Forge $10.5 Billion Oncology Partnership, Boosting Innovent Shares

Pfizer and Innovent Biologics Forge $10.5 Billion Oncology Partnership, Boosting Innovent Shares
Trendline Trendline
Innovent Biologics Shares Surge After $10.5 Billion Deal with Pfizer

Innovent Biologics Shares Surge After $10.5 Billion Deal with Pfizer

Innovent Biologics Shares Surge After $10.5 Billion Deal with Pfizer
Trendline Trendline
Vyome Holdings Reports Q1 2026 Financial Results, Highlights Regulatory and Clinical Progress

Vyome Holdings Reports Q1 2026 Financial Results, Highlights Regulatory and Clinical Progress

Vyome Holdings Reports Q1 2026 Financial Results, Highlights Regulatory and Clinical Progress
Trendline Trendline
Vyome Holdings Reports Q1 2026 Financial Results with Net Loss and Strategic Developments

Vyome Holdings Reports Q1 2026 Financial Results with Net Loss and Strategic Developments

Vyome Holdings Reports Q1 2026 Financial Results with Net Loss and Strategic Developments
Trendline Trendline
Kailera Therapeutics Follows Eli Lilly's Lead with Record-Breaking IPO and Obesity Drug Pipeline

Kailera Therapeutics Follows Eli Lilly's Lead with Record-Breaking IPO and Obesity Drug Pipeline

Kailera Therapeutics Follows Eli Lilly's Lead with Record-Breaking IPO and Obesity Drug Pipeline
Trendline Trendline
Nektar Therapeutics to Present at 2026 Jefferies Global Healthcare Conference

Nektar Therapeutics to Present at 2026 Jefferies Global Healthcare Conference

Nektar Therapeutics to Present at 2026 Jefferies Global Healthcare Conference
Trendline Trendline
Turn Therapeutics Publishes Study on GX-03's Efficacy in Inflammatory Skin Disease Model

Turn Therapeutics Publishes Study on GX-03's Efficacy in Inflammatory Skin Disease Model

Turn Therapeutics Publishes Study on GX-03's Efficacy in Inflammatory Skin Disease Model
Trendline Trendline
Kura Oncology's New Cancer Drug Shows Promise, Potential $2 Billion Market Opportunity

Kura Oncology's New Cancer Drug Shows Promise, Potential $2 Billion Market Opportunity

Kura Oncology's New Cancer Drug Shows Promise, Potential $2 Billion Market Opportunity
Trendline Trendline
Kardigan Files for IPO to Fund Cardiovascular Drug Development

Kardigan Files for IPO to Fund Cardiovascular Drug Development

Kardigan Files for IPO to Fund Cardiovascular Drug Development
Trendline Trendline
Kardigan Prepares for IPO to Fund Cardiovascular Drug Development

Kardigan Prepares for IPO to Fund Cardiovascular Drug Development

Kardigan Prepares for IPO to Fund Cardiovascular Drug Development